Artemis Medicare Services Statistics

Total Valuation

NSE:ARTEMISMED has a market cap or net worth of INR 36.84 billion. The enterprise value is 36.21 billion.

Market Cap	36.84B
Enterprise Value	36.21B

Important Dates

The next estimated earnings date is Friday, May 8, 2026.

Earnings Date	May 8, 2026
Ex-Dividend Date	Jul 11, 2025

Share Statistics

NSE:ARTEMISMED has 158.31 million shares outstanding. The number of shares has increased by 4.74% in one year.

Current Share Class	158.31M
Shares Outstanding	158.31M
Shares Change (YoY)	+4.74%
Shares Change (QoQ)	-0.08%
Owned by Insiders (%)	3.08%
Owned by Institutions (%)	1.83%
Float	32.29M

Valuation Ratios

The trailing PE ratio is 38.04 and the forward PE ratio is 29.46. NSE:ARTEMISMED's PEG ratio is 1.06.

PE Ratio	38.04
Forward PE	29.46
PS Ratio	3.54
PB Ratio	4.15
P/TBV Ratio	4.44
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	1.06

Financial Ratio History

Enterprise Valuation

EV / Earnings	37.48
EV / Sales	3.48
EV / EBITDA	20.87
EV / EBIT	28.53
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.31
Debt / EBITDA	1.61
Debt / FCF	n/a
Interest Coverage	4.94

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	11.69%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	4.18%
Revenue Per Employee	5.02M
Profits Per Employee	465,173
Employee Count	2,077
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, NSE:ARTEMISMED has paid 312.32 million in taxes.

Income Tax	312.32M
Effective Tax Rate	24.48%

Stock Price Statistics

The stock price has increased by +0.10% in the last 52 weeks. The beta is -0.05, so NSE:ARTEMISMED's price volatility has been lower than the market average.

Beta (5Y)	-0.05
52-Week Price Change	+0.10%
50-Day Moving Average	245.29
200-Day Moving Average	250.46
Relative Strength Index (RSI)	45.59
Average Volume (20 Days)	164,944

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:ARTEMISMED had revenue of INR 10.42 billion and earned 966.16 million in profits. Earnings per share was 6.12.

Revenue	10.42B
Gross Profit	2.21B
Operating Income	1.27B
Pretax Income	1.28B
Net Income	966.16M
EBITDA	1.66B
EBIT	1.27B
Earnings Per Share (EPS)	6.12

Full Income Statement

Balance Sheet

The company has 3.48 billion in cash and 2.79 billion in debt, giving a net cash position of 688.30 million or 4.35 per share.

Cash & Cash Equivalents	3.48B
Total Debt	2.79B
Net Cash	688.30M
Net Cash Per Share	4.35
Equity (Book Value)	8.88B
Book Value Per Share	55.96
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 21.24%, with operating and profit margins of 12.18% and 9.27%.

Gross Margin	21.24%
Operating Margin	12.18%
Pretax Margin	12.25%
Profit Margin	9.27%
EBITDA Margin	15.94%
EBIT Margin	12.18%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.45, which amounts to a dividend yield of 0.19%.

Dividend Per Share	0.45
Dividend Yield	0.19%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.74%
Shareholder Yield	-4.55%
Earnings Yield	2.62%
FCF Yield	n/a

Dividend Details

Stock Splits

The last stock split was on September 23, 2021. It was a forward split with a ratio of 10.

Last Split Date	Sep 23, 2021
Split Type	Forward
Split Ratio	10

Scores

Altman Z-Score	n/a
Piotroski F-Score	1